Intelligence Β· Patent portfolio
Regeneron Ireland Designated Patents
Full USPTO pharma patent portfolio for Regeneron Ireland Designated β grant dates, expiration, and drug cross-links.
- Patents
- 8,292
- Expiring β€24m
- 426
Quick answer
Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β use filters for patent-cliff planning.
-
US 6083750
Adenovirus vectors
expired -
US 6083691
Detection of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients
expired -
US 6080386
Suspended ultra-sound induced microbubble cavitation imaging
expired -
US 6080791
Method of treating a viral condition by inhibiting membrane fusion
expired -
US 6080588
Therapeutic methods for benzodiazepine derivatives
expired -
US 6077516
Live vaccine against colibacillosis
expired -
US 6077680
ShK toxin compositions and methods of use
expired -
US 6077514
Attenuated respiratory syncytial virus
expired -
US 6077515
Flagella-less borrelia
expired -
US 6077510
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
expired -
US 6074840
Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
expired -
US 6075134
Glycoconjugates and methods
expired -
US 6075007
Modified noggin polypeptide and compositions
expired -
US 6075027
Treatment and prevention of hepatic disorders
expired -
US 6075044
Heterocyclic derivatives as inhibitors of purine salvage phosphoribosyltransferases
expired -
US 6074646
Nondenatured HIV envelope antigens for detecting early HIV-specific antibodies
expired -
US 6071533
Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
expired -
US 6071715
Nucleic acids encoding novel proteins which bind to retinoblastoma protein
expired -
US 6071737
Equine Neospora isolate and its uses
expired -
US 6071955
FXR, PPARA and LXRA activators to treat acne/acneiform conditions
expired -
US 6071879
Method for the treatment of bacterial infection
expired -
US 6071891
Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
expired -
US 6072038
Conjugates of texaphyrins
expired -
US 6071742
Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
expired -
US 6071518
GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium
expired -
US 6069140
Pharmaceutical compositions comprising texaphyrins
expired -
US 6069167
Use of antioxidant agents to treat cholestatic liver disease
expired -
US 6069146
Halimide, a cytotoxic marine natural product, and derivatives thereof
expired -
US 6069134
Methods and compositions comprising DNA damaging agents and p53
expired -
US 6068843
Nucleotide sequences and methods for detection of Serpulina hyodysenteriae
expired -
US 6069283
Illudin analogs useful as antitumor agents
expired -
US 6066778
Transgenic mice expressing APC resistant factor V
expired -
US 6066675
Method for treatment of retinal diseases
expired -
US 6066337
Method for producing a rapidly dissolving dosage form
expired -
US 6063622
Adenovirus vectors
expired -
US 6060270
Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
expired -
US 6060311
Retinoid suppression of ventricular muscle cell hypertrophy
expired -
US 6060582
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
expired -
US 6060515
Treatment of skin conditions by use of PPAR.alpha. activators
expired -
US 6060500
Suppression, by 5-lipoxygenase inhibitors, of bone resorption
expired -
US 6060238
Method and composition for regulating apoptosis
expired -
US 6057300
Methods for treating cancers and restenosis with p21
expired -
US 6057158
Adenovirus vectors
expired -
US 6054427
Methods and compositions for optimization of oxygen transport by cell-free systems
expired -
US 6054133
Anti-microbial targeting for intracellular pathogens
expired -
US 6054433
Methods and compositions for stimulating tissue growth and epithelial moisturization
expired -
US 6054293
Semaphorin receptors
expired -
US 6054442
Methods and compositions for modulation and inhibition of telomerase in vitro
expired
Frequently asked questions
How many patents does Regeneron Ireland Designated have?
8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Regeneron Ireland Designated patents expire?
426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory